• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性肝病患者粪便钙卫蛋白浓度的纵向研究。

Fecal calprotectin concentrations in alcoholic patients: a longitudinal study.

机构信息

Institute of Internal Medicine, Catholic University of Rome, Italy.

出版信息

Eur J Gastroenterol Hepatol. 2011 Jan;23(1):76-80. doi: 10.1097/MEG.0b013e32834101f9.

DOI:10.1097/MEG.0b013e32834101f9
PMID:21030869
Abstract

OBJECTIVES

Excessive alcohol consumption often results in intestinal damage, mediated by inflammatory processes, mainly characterized by an increased influx of leukocytes. Fecal calprotectin is a granulocyte cytosolic protein, representing as a promising marker of subclinical intestinal inflammation. In this study, we assessed fecal calprotectin concentrations (FCCs) in current drinking alcoholics, both at the baseline, and then during a subsequent 84-day period. Moreover, FCCs in the alcoholics were compared with the FCCs in healthy controls.

METHODS

Twenty-eight, active-drinking alcoholics were enrolled in this study and compared with 40 healthy volunteers as the control group. In alcoholics, FCCs were determined at the beginning of the study (baseline; T0) and then every 2 weeks (T1-T6) during the following 84-day period. Potential differences in FCCs were analyzed between alcoholics and healthy controls, and during the 84-day period within the group of alcoholics. In addition, an analysis of FCCs was conducted in three subgroups of alcoholics, considering their drinking status during the 84-day period (abstinent, relapsed, and active).

RESULTS

At baseline, no significant differences in median FCCs were found between alcoholics and controls. No significant changes of median FCCs were found, comparing baseline FCCs and FCCs during the 84-day period (T1-T6) in the whole group of alcoholics, nor in the three subgroups of alcoholics.

CONCLUSION

FCCs in active-drinking alcoholics are not significantly different, compared with the healthy controls. Moreover, FCCs do not significantly differ according to the alcohol drinking status. These results may suggest the absence of a subclinal intestinal inflammation involving neutrophils in the alcoholics.

摘要

目的

过量饮酒常导致肠道损伤,这一过程主要通过炎症反应介导,其特征主要为白细胞的过度涌入。粪便钙卫蛋白是一种粒细胞胞质蛋白,是一种有前途的亚临床肠道炎症标志物。在本研究中,我们评估了当前饮酒酗酒者的粪便钙卫蛋白浓度(FCCs),并在随后的 84 天期间进行了评估。此外,我们还将酗酒者的 FCCs 与健康对照组的 FCCs 进行了比较。

方法

本研究共纳入 28 名活跃饮酒的酗酒者,并与 40 名健康志愿者作为对照组进行比较。在酗酒者中,FCCs 在研究开始时(基线;T0)确定,然后在接下来的 84 天期间每两周(T1-T6)确定一次。分析了酗酒者与健康对照组之间以及酗酒者组内 84 天期间 FCCs 的潜在差异。此外,还对考虑到 84 天期间酗酒者饮酒状况的三个亚组的 FCCs 进行了分析(禁欲、复发和活跃)。

结果

基线时,酗酒者和对照组的 FCCs 中位数无显著差异。在整个酗酒者组以及三个酗酒者亚组中,基线 FCCs 与 84 天期间的 FCCs(T1-T6)之间的 FCCs 中位数均未发生显著变化。

结论

与健康对照组相比,活跃饮酒的酗酒者的 FCCs 没有显著差异。此外,根据饮酒状况,FCCs 也没有显著差异。这些结果可能表明,酗酒者不存在涉及中性粒细胞的亚临床肠道炎症。

相似文献

1
Fecal calprotectin concentrations in alcoholic patients: a longitudinal study.酒精性肝病患者粪便钙卫蛋白浓度的纵向研究。
Eur J Gastroenterol Hepatol. 2011 Jan;23(1):76-80. doi: 10.1097/MEG.0b013e32834101f9.
2
Fecal calprotectin is a useful screening parameter for hepatic encephalopathy and spontaneous bacterial peritonitis in cirrhosis.粪便钙卫蛋白是肝硬化肝性脑病和自发性细菌性腹膜炎的有用筛查参数。
Liver Int. 2011 Oct;31(9):1406-15. doi: 10.1111/j.1478-3231.2011.02577.x.
3
Faecal calprotectin concentrations in untreated coeliac patients.未经治疗的乳糜泻患者的粪便钙卫蛋白浓度。
Scand J Gastroenterol. 2007 Aug;42(8):957-61. doi: 10.1080/00365520601173632.
4
[Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report].[儿童炎症性肠病中粪便钙卫蛋白浓度作为炎症标志物的评估——初步报告]
Pol Merkur Lekarski. 2010 Oct;29(172):241-6.
5
Comparison of a novel fecal marker--fecal tumor pyruvate kinase type M2 (M2-PK) with fecal calprotectin in patients with inflammatory bowel disease: a prospective study.新型粪便标志物——粪便肿瘤型丙酮酸激酶M2(M2-PK)与粪便钙卫蛋白在炎症性肠病患者中的比较:一项前瞻性研究。
Clin Lab. 2008;54(9-10):389-90.
6
Evaluation of calprotectin level in intestinal content as an early marker for graft rejection.评估肠道内容物中钙卫蛋白水平作为移植排斥反应的早期标志物。
Transplant Proc. 2010 Jan-Feb;42(1):57-61. doi: 10.1016/j.transproceed.2009.12.013.
7
Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease.在患有炎症性肠病的儿童接受糖皮质激素治疗期间,粪便钙卫蛋白水平持续偏高。
Scand J Gastroenterol. 2006 Jun;41(6):720-5. doi: 10.1080/00365520500419623.
8
Fecal calprotectin concentrations in patients with small intestinal bacterial overgrowth.小肠细菌过度生长患者的粪便钙卫蛋白浓度
Dig Dis. 2008;26(2):183-6. doi: 10.1159/000116777. Epub 2008 Apr 21.
9
Fecal lactoferrin and calprotectin after ileocolonic resection for Crohn's disease.克罗恩病回结肠切除术后的粪便乳铁蛋白和钙卫蛋白
Dis Colon Rectum. 2007 Jun;50(6):861-9. doi: 10.1007/s10350-007-0225-6.
10
Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.炎症性肠病中的直肠一氧化氮和粪便钙卫蛋白
Scand J Gastroenterol. 2007 Oct;42(10):1151-7. doi: 10.1080/00365520701320505.

引用本文的文献

1
Elevated calprotectin levels are associated with mortality in patients with acute decompensation of liver cirrhosis.血清钙卫蛋白水平升高与肝硬化急性失代偿患者的死亡率相关。
World J Hepatol. 2022 Nov 27;14(11):1964-1976. doi: 10.4254/wjh.v14.i11.1964.
2
Markers of bacterial translocation in end-stage liver disease.终末期肝病中细菌易位的标志物。
World J Hepatol. 2015 Sep 18;7(20):2264-73. doi: 10.4254/wjh.v7.i20.2264.
3
Is moderate red wine consumption safe in inactive inflammatory bowel disease?在非活动性炎症性肠病中,适量饮用红酒是否安全?
Digestion. 2011;84(3):238-44. doi: 10.1159/000329403. Epub 2011 Aug 26.